Long‐term survival of a patient with refractory advanced adrenocortical carcinoma after combination chemotherapy with paclitaxel and carboplatin plus mitotane

INTRODUCTION: The prognosis of patients with unresectable adrenocortical carcinoma is poor. Mitotane is the first‐line treatment for this disease, and etoposide/doxorubicin/cisplatin/mitotane therapy is recommended as first‐line chemotherapy in unresponsive cases. We present a case of long‐term surv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayakawa, Yuki, Hamamoto, Shuzo, Kamisawa, Hideyuki, Okada, Shinsuke, Taguchi, Kazumi, Naiki, Taku, Okada, Atsushi, Tozawa, Keiichi, Yasui, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249639/
https://www.ncbi.nlm.nih.gov/pubmed/35795129
http://dx.doi.org/10.1002/iju5.12458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249639/
https://www.ncbi.nlm.nih.gov/pubmed/35795129
http://dx.doi.org/10.1002/iju5.12458

Ejemplares similares